About Equator Therapeutics
Equator Therapeutics is a company based in San Francisco (United States) founded in 2019. Equator Therapeutics has raised $125 thousand across 2 funding rounds from investors including HHS and Y Combinator. The company has 3 employees as of December 31, 2024. Equator Therapeutics offers products and services including Thermogenesis Drug and High-Throughput Assays. Equator Therapeutics operates in a competitive market with competitors including Adocia, Altimmune, Carmot, BioAge Labs and Fractyl, among others.
- Headquarter San Francisco, United States
- Employees 3 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Equator Therapeutics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$125 K (USD)
in 2 rounds
-
Latest Funding Round
$1.91 M (USD), Grant
Sep 20, 2021
-
Investors
HHS
& 1 more
-
Employee Count
3
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Equator Therapeutics
Equator Therapeutics offers a comprehensive portfolio of products and services, including Thermogenesis Drug and High-Throughput Assays.
Stimulates mitochondrial heat production for sustained weight loss.
Identifies compounds for safe thermogenic activation in mitochondria.
People of Equator Therapeutics
Unlock access to complete
Unlock access to complete
Leadership Team
3 people
Advisor Team
3 people
Scientific Team
1 people
Scientist Team
1 people
Head Team
1 people
Unlock access to complete
Funding Insights of Equator Therapeutics
Equator Therapeutics has successfully raised a total of $125K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.91 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Equator Therapeutics
Equator Therapeutics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Equator Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Equator Therapeutics
Investment portfolio details for Equator Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Equator Therapeutics
Detailed financials for Equator Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Equator Therapeutics Comparisons
Peer comparison for Equator Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Equator Therapeutics
Equator Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Altimmune, Carmot, BioAge Labs and Fractyl, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| Locked | Locked | Locked |
Disease-modifying therapies for metabolic diseases are developed.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
|
| Locked | Locked | Locked |
Peptide-based therapies for obesity and cardiometabolic disorders are developed.
|
Detailed competitors of Equator Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Equator Therapeutics
Complete news archive for Equator Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Equator Therapeutics
Equator Therapeutics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Equator Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Jonah Sinick is the current CEO of Equator Therapeutics.
Equator Therapeutics is a funded company, having raised a total of $125K across 2 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Equator Therapeutics is 3.
Equator Therapeutics was founded in 2019 and is based in San Francisco, United States. Operations focus on the biotechnology sector, where mitochondria-targeting drugs are developed to address metabolic disorders. Research efforts center on enhancing calorie expenditure and improving overall metabolic function through innovative therapeutic approaches. The company is led by CEO Jonah Sinick, with activities conducted primarily in the U.S.
Equator Therapeutics's top competitors include Adocia, BioAge Labs and Fractyl.
Equator Therapeutics offers Thermogenesis Drug and High-Throughput Assays.
Equator Therapeutics has 2 investors. Key investors include HHS, and Y Combinator.